ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $35,961 | +11.6% | 6,309 | +15.3% | 0.00% | – |
| Q4 2022 | $32,236 | -25.0% | 5,473 | -59.6% | 0.00% | – |
| Q3 2022 | $43,000 | -28.3% | 13,563 | +1.1% | 0.00% | – |
| Q2 2022 | $60,000 | -85.1% | 13,416 | -82.3% | 0.00% | -100.0% |
| Q1 2022 | $404,000 | +797.8% | 75,599 | +3424.4% | 0.00% | +200.0% |
| Q3 2021 | $45,000 | -76.9% | 2,145 | -80.5% | 0.00% | -50.0% |
| Q2 2021 | $195,000 | +490.9% | 11,024 | +716.6% | 0.00% | – |
| Q1 2021 | $33,000 | -90.8% | 1,350 | -87.3% | 0.00% | -100.0% |
| Q2 2020 | $357,000 | – | 10,598 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |